30 years of experience in academia and drug R&D (Novartis). Senior scientist and project team head for various preclinical dermatology projects.
Dr. Barbara Wolff-Winiski, MBA worked at Novartis for 25 years. She established diverse in vitro, in vivo and ex vivo assays to profile lead compounds for inflammatory skin diseases and skin cancer. In 2012 she received the Novartis 3R Animal Welfare Award for the development of an in vitro organotypic 3D keratinocyte model of Netherton disease. As Project Team Head and lead scientist, she provided pivotal preclinical data to advance new medical entities to clinical development, e.g., inhibitors of protein kinase C, smoothened and proteases.